Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Weimai Qingtong Medical Technology

Request full access

AI-powered full-cycle digital healthcare management platform.

ChinaFounded 2021Health Tech & Medtech

About Weimai Qingtong Medical Technology

Weimai Qingtong Medical Technology, operating as Weimai, is a digital healthcare solutions provider headquartered in Hangzhou, China. Founded in 2015 by Qiu Jialin, who serves as the company's CEO, Weimai has established itself as a significant online platform for full-cycle healthcare management in the country. The company's business model is centered around the concept of a "managed care organization" (MCO), which it has adapted for the Chinese market and refers to as C-MCO.

Weimai's core offering is an integrated healthcare management service that utilizes AI and digital tools to connect care across pre-hospital, in-hospital, and post-hospital settings. This platform is designed to address patient needs following diagnosis, testing, surgery, and hospitalization, encompassing services like medication management, follow-up consultations, and guidance on diet, exercise, and rehabilitation. By integrating online and offline care, the company aims to enhance the efficiency and quality of healthcare services while improving patient outcomes. Its proprietary CareAI technology is a key component in driving the adoption of its comprehensive care management solutions.

The company serves a large market, and as of the end of 2024, it had connected with over 2,500 public healthcare institutions and 200,000 licensed doctors across China, having served a cumulative total of one billion patients. Weimai has successfully raised significant funding to fuel its expansion and technological development. In January 2025, the company secured 200 million yuan (approximately $27.3 million) in a Series D funding round. This round saw participation from new investors, including CNCB Investment, Choice Capital, and Yuhang Transformation Industry Investment, as well as existing shareholders like Source Code Capital and Cenova Ventures. The capital is intended to further the development of its disease management solutions and AI-related research.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.7/100
Industry
Health, Wellness Beauty
Sub-industry
Medical Devices
Sector
Skin Care, Health and Beauty, Core AI, Wellness and Beauty
Technology
Artificial Intelligence
Business model
Marketplace & ecommerce
Client focus
B2C
Links
Website

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Mar 2026 $2.8M $69M SBI Group ↗
SERIES B✓Equity / VC Feb 2025 $2.8M $69M Wuxi Innovation Investment Group ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Weimai Qingtong Medical Technology website traffic

Latest recorded traffic for Weimai Qingtong Medical Technology is 1.4K monthly website visits, down 26.3% over the last three months.

Latest monthly visits1.4K 3-month web change-26.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Weimai Qingtong Medical Technology in its local ecosystem

Live from Dealroom

The Weimai Qingtong Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Yunnan Botanee Bio-Tech Group
  • Xiamen Hengxing Group
  • CDH Investments
  • Chuchang Investment Group
  • Bangqin Capital
  • Wuxi Innovation Investment Group

Series B and later1 investor entered at this stage

  • SBI Group
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Weimai Qingtong Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Weimai Qingtong Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.